Decision aid for low-risk thyroid cancer
Part of Cancer, Hormones & metabolism clinical trials.
This study tests a decision aid to help people with low-risk thyroid cancer or suspicious nodules make informed choices about their care. It may help you understand your options and feel more confident in your decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a thyroid nodule that is suspicious for cancer or a low-risk thyroid cancer.
- You speak English.
- You have not yet talked to a surgeon about this thyroid nodule or cancer.
- You have no high-risk features, like spread outside the thyroid seen on ultrasound.
- You have never had thyroid cancer or thyroid surgery before.
- You are not currently pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether it is safe to monitor small, low-risk thyroid cancers (1–4 cm) instead of removing the remaining thyroid tissue after initial surgery. It may help you avoid a second operation and lifelong medication if your cancer is truly low-risk.
This study looks at how doctors and patients can decide together on the best way to treat low-risk thyroid cancer. It aims to help you choose a treatment that fits your values and needs, while keeping your cancer under control.
This trial tests whether it is safe to avoid immediate surgery and instead monitor small thyroid cancers that are considered low-risk. If you join, doctors will check regularly to make sure the cancer does not grow or spread.
This study looks at whether closely watching (without immediate surgery or treatment) a very small thyroid cancer can be safe. You may benefit by avoiding unnecessary procedures, while the team monitors your thyroid and any changes over time.
This study looks at how thyroid nodule biopsy results (Bethesda classification) relate to the final diagnosis of differentiated thyroid cancer, to help predict risk and guide treatment.
This trial offers a decision aid to help you choose whether to have radioactive iodine (RAI) treatment after thyroid cancer surgery. You may qualify if you have intermediate-risk thyroid cancer and haven't yet made a decision about RAI.
Hear when a new Papillary Thyroid Microcarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.